sglt2 inhibitors vs glp 1 agonists and GLP-1 receptor agonists: a sound combination SGLT2 inhibitors or GLP-1 receptor
Description
Creange C, Lin E, Ren-Fielding C, Lofton H

A study that investigated the effects of insulin and GLP-1RAs (exenatide and dulaglutide) on BMD over a 52-week duration gathered 70 individuals with type 2 diabetes

Faulkner G, Cohn T, Remington G, Irving H

Staying informed through resources like SeekPeptides ensures you are positioned to take advantage of expanded eligibility as it develops

Biol Psychiatry (2020) 87(9):797807
